Any feedback?
Literature summary for 3.4.16.2 extracted from
- Prolylcarboxypeptidase: A cardioprotective enzyme (2009), Int. J. Biochem. Cell Biol., 41, 477-481.
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | the validity of prolylcarboxypeptidase as a site specific therapeutic that could mitigate inflammatory injury is discussed | Homo sapiens |
Molecular Weight [Da]
| Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
|---|---|---|---|
| 55800 | - |
- |
Homo sapiens |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
Posttranslational Modification
| Posttranslational Modification | Comment | Organism |
|---|---|---|
| glycoprotein | prolylcarboxypeptidase has six potential N-glycosylation sites, suggesting that it undergoes post-translational modifications | Homo sapiens |
Subunits
| Subunits | Comment | Organism |
|---|---|---|
| homodimer | - |
Homo sapiens |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| PRCP | - |
Homo sapiens |
| prolylcarboxypeptidase | - |
Homo sapiens |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
